返回 Agenda
Session 6, Track A and B: Insights into Rare Diseases: Pioneering Pathways for Patient Access and Drug Development
Session Chair(s)
Brenda Gryfe, MSc
Director, Regulatory Affairs
TPIreg, Innomar Strategies, Canada
Amber McLeod, PhD
Immunology, Virology, and Specialty Head, Regulatory Affairs
Abbvie Corporation, Canada
Session 6, Tracks A and B: Insights into Rare Diseases: Pioneering Pathways for Patient Access and Drug Development